- Comprehensive historical data illustrates improvements in
environmental metrics, highly engaged workforce, community and
veterinary support, and ambitions for a more diverse and inclusive
workforce
- Addition of new leaders and responsibilities dedicated to ESG
areas
Zoetis (NYSE:ZTS) today announced publication of its 2019
Environmental, Social and Governance (ESG) Review, providing more
information on its ESG initiatives, including disclosures on
energy, waste and workforce metrics. This marks the animal health
industry’s first stand-alone disclosure of key performance
indicators based on the Sustainability Accounting Standards Board
(SASB) and Taskforce on Climate-related Financial Disclosures
(TCFD), which are leading global sustainability frameworks.
The review focuses on recent ESG activities and metrics, with
progress dating back to 2017, while highlighting important steps
Zoetis has taken in its sustainability journey. Guided by a belief
that healthier animals will help create a healthier future, earlier
this year Zoetis outlined three ways the company contributes to
healthier animals: care and collaborate through partnerships and
support of colleagues and communities; innovate in animal health to
help solve sustainability challenges faced by animals and people;
and, protect the planet by stewarding resources and minimizing the
direct impact of the company’s operations. In conjunction with the
release of its comprehensive ESG review, Zoetis also enhanced its
Policy on Sustainability to include its commitment to protect the
planet, develop innovative animal health products, and support
colleagues and communities.
“As a company focused on the health of animals, sustainability
has always been integral to our work; however, this year we
formalized our strategy and elevated sustainability to one of our
top priorities,” said Kristin Peck, Chief Executive Officer of
Zoetis. “In the face of the global pandemic, it has been more
critical than ever to care for the needs of our colleagues,
customers and communities and define our plan to create a
healthier, more sustainable future. We look forward to sharing more
about our goals and progress in 2021 and beyond.”
Key Leadership Roles
In prioritizing sustainability, Zoetis appointed four leaders
this year to oversee various aspects of the company’s
commitments.
- Jeannette Ferran Astorga joined the company as its first Head
of Sustainability responsible for stewarding the company strategy
and tracking accountability for its commitments, partnerships and
philanthropy. This year Ferran Astorga was named to Assent’s Top
100 Corporate Social Responsibility Influence Leaders for her
leadership and influence to help others start or improve corporate
social responsibility programs.
- Mike McFarland, DVM, was named global Chief Medical Officer
(CMO). As a respected veterinarian and expert in animal health, Dr.
McFarland is a member of the Zoetis Executive Team with
responsibility for Global Commercial Development, Customer
Experience and Sustainability.
- Evelyn Ortiz was appointed Chief Talent, Diversity, Equity and
Inclusion Officer to manage Zoetis’ activities to enhance
diversity, equity and inclusion within its culture and across its
colleague population. Ortiz’s role also includes partnerships with
suppliers and vendors and in the communities where we work.
- Jeff Williams was named Chief Compliance Officer. Williams, who
joined Zoetis recently from the National Geographic Society and has
a background in the pharmaceutical industry, administers the
company’s Enterprise Risk Management program.
Creating an Inclusive, Safe and Engaged Workplace
This year Zoetis committed to accelerating inclusion, equity and
more diverse representation across the company. By 2025 the company
aspires to:
- Increase representation of women at the director level and
above from 32% to 40%
- Increase overall representation among people of color in the
U.S. from 21% to 25%
- Increase representation of Black colleagues in the U.S. from 4%
to 5%
- Increase representation of Latinx colleagues in the U.S. from
5% to 6%
Zoetis’ Employee Health & Safety programs have resulted in
strong safety performance, as demonstrated by total injury rate
(TIR) and lost time injury rate (LTIR) being lower than the U.S.
industry averages.
In cultivating a sustainable workplace, Zoetis regularly
assesses colleague engagement and key drivers of organizational
performance through employee surveys. The company’s strong
colleague engagement has grown from 81% in 2016, to 85% in 2018,
and to 90% in the first wave of feedback in 2020.
Environmental
As Zoetis grows its business in a way that is considerate of our
global community, we are committed to protecting our planet by
using the world’s resources wisely and reducing our emissions and
waste. Since 2017, Zoetis has:
- Reduced its greenhouse gas emissions intensity1,2 (4%
less)
- Reduced its water intake intensity3,4 (5% less)
- Reduced its hazardous waste intensity4,5 (9% less)
- Reduced its solid waste intensity4,5 (87% less)
- Improved its recycling rate of hazardous waste (35% increase)
and solid waste (14% increase) 4,5.
Even as the company grows to fulfill the needs of people who
care for animals, Zoetis is fully committed to continuing to reduce
its environmental footprint and plans to adopt specific goals that
will be shared in 2021.
Veterinary and Community Support
Zoetis has long supported the veterinary profession through a
variety of philanthropic initiatives including its ongoing Zoetis
Veterinary Student Scholarship partnership with the Association of
American Veterinary Medical Colleges that awarded 315 veterinary
students $630,000 in scholarship funds for the 2020 academic year.
The program has given $7.3 million to more than 3,600 veterinary
students over the past 11 years. The company has similar programs
in Canada and the United Kingdom and has also supported veterinary
education efforts in China, Egypt and other countries to help
ensure a bright future for the veterinary profession.
The company takes a grass roots approach to care and collaborate
in local communities where it has a presence, including:
- In Australia, Zoetis raised $300,000 for Beyond Blue over the
last three years to help Australian farmers and veterinarians who
are vulnerable to mental health challenges as a result of rural
isolation. The company also made available $400,000 in donated
product to help veterinarians care for animals affected by the 2019
Australian bushfires.
- In Brazil, Zoetis collaborated with Patas Therapeuticas
(Therapeutic Paws) to provide vaccines for specially trained dogs
visiting hospitals to comfort patients, and the company worked with
the Magnus Institute to provide vaccines and facilitate training
for dogs to become guides for people with visual and movement
disabilities.
- In the U.S., Zoetis donated over $500,000 in products to help
local veterinarians care for animals affected by natural disasters
in 2019 including floods and hurricanes.
The company is establishing a framework to collect data on a
global scale that can quantify efforts in the future.
Animal Health Product Safety, Research and Quality
Assurance
Scientists in Zoetis’ research and development organization are
dedicated to helping animals live longer, healthier lives through
the discovery and development of breakthrough medicines and
therapies. All animals in the company’s clinical trials are cared
for according to the company’s policy on animal care and welfare.
In addition, Zoetis has a comprehensive program to ensure the
responsible use of antibiotics, advocating for veterinary
involvement when antibiotics must be used, innovating to discover
new and enhanced solutions for animal care, and collaborating in a
“One Health” approach with human and veterinary medicine
professionals.
To continue to identify environmental, social and governance
areas in which to improve, Zoetis has undertaken a materiality
assessment with key stakeholders. This will partly inform a more
comprehensive sustainability report in 2021 that will include
environmental goals and alignment with the United Nations
Sustainable Development Goals.
About Zoetis
Zoetis is the leading animal health company, dedicated to
supporting its customers and their businesses. Building on more
than 65 years of experience in animal health, Zoetis discovers,
develops, manufactures and commercializes medicines, vaccines and
diagnostic products, which are complemented by biodevices, genetic
tests and precision livestock farming. Zoetis serves veterinarians,
livestock producers and people who raise and care for farm and
companion animals with sales of its products in more than 100
countries. In 2019, the company generated annual revenue of $6.3
billion with approximately 10,600 employees. For more information,
visit www.zoetis.com.
DISCLOSURE NOTICES
Forward-Looking Statements: This press release contains
forward-looking statements, which reflect the current views of
Zoetis with respect to: business plans or prospects, ESG
commitments, goals and aspirations, and other future events. These
statements are not guarantees of future performance or actions.
Forward-looking statements are subject to risks and uncertainties.
If one or more of these risks or uncertainties materialize, or if
management's underlying assumptions prove to be incorrect, actual
results may differ materially from those contemplated by a
forward-looking statement. Forward-looking statements speak only as
of the date on which they are made. Zoetis expressly disclaims any
obligation to update or revise any forward-looking statement,
whether as a result of new information, future events or otherwise.
A further list and description of risks, uncertainties and other
matters can be found in our Annual Report on Form 10-K for the
fiscal year ended December 31, 2019, including in the sections
thereof captioned “Forward-Looking Statements and Factors That May
Affect Future Results” and “Item 1A. Risk Factors,” in our
Quarterly Reports on Form 10-Q and in our Current Reports on Form
8-K. These filings and subsequent filings are available online at
www.sec.gov, www.zoetis.com, or on request from Zoetis.
1 Emissions intensity (metric tons CO2e/$1MM revenue)
2 These metrics cover our Global Manufacturing and Supply,
Veterinary Medical Research and Development, and other operations
not including stand-alone office spaces. These emissions account
for more than 99% of our operational emissions.
3 Water intake intensity (cubic meters/$1MM revenue)
4 These metrics cover our Global Manufacturing and Supply,
Veterinary Medical Research and Development, and other operations
not including stand-alone office spaces.
5 Hazardous and solid waste recycled intensity (kilograms/$1MM
revenue)
All trademarks are the property of Zoetis Services LLC or a
related company or a licensor unless otherwise noted.
© 2020 Zoetis Services LLC. All rights reserved.
ZTS-COR ZTS-IR
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201116005387/en/
Media: Christina Lood
1-973-822-7249 (o) christina.lood@zoetis.com Bill Price
1-973-443-2742 (o) william.price@zoetis.com Investors: Steve Frank 1-973-822-7141 (o)
steve.frank@zoetis.com Keith Gaub 1-973-822-7154 (o)
keith.gaub@zoetis.com
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Jul 2023 to Jul 2024